Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Gudin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy|March 27, 2013
Assessment of extended-release opioid analgesics for the treatment of chronic painJeffrey A Gudin
Therapeutics and Clinical Risk Management|May 10, 2012
The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation StrategyJeffrey A Gudin
Postgraduate Medicine|June 14, 2012
Clinical strategies for the primary health care professional to minimize prescription opioid abuseJeffrey A Gudin
The American Journal of Medicine|September 4, 2007
Opioid agreement or patient-centric action plan?Jeffrey A Gudin
Postgraduate Medicine|December 1, 2015
An overview of prodrug technology and its application for developing abuse-deterrent opioidsJeffrey A Gudin, Srinivas R Nalamachu
Postgraduate Medicine|October 9, 2019
The prescription opioid conundrum: 21st century solutions to a millennia-long problemMichael J Brennan, Jeffrey A Gudin
Pain Medicine (Malden, Mass.)|October 14, 2015
Opioid Related EndocrinopathyJeffrey A Gudin, Adam Laitman, Srinivas Nalamachu
Journal of Pain Research|July 4, 2020
Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the RELIEF StudyJeffrey A Gudin, Derek T Dietze, Peter L Hurwitz
Postgraduate Medicine|August 13, 2013
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol useJeffrey A Gudin, Shanthi Mogali, Jermaine D Jones, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 8, 2013
Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl productsJoseph V Pergolizzi, Christopher G Gharibo, Jeffrey A Gudin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Pain & Palliative Care Pharmacotherapy|March 27, 2013
Assessment of extended-release opioid analgesics for the treatment of chronic painJeffrey A Gudin
Therapeutics and Clinical Risk Management|May 10, 2012
The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation StrategyJeffrey A Gudin
Postgraduate Medicine|June 14, 2012
Clinical strategies for the primary health care professional to minimize prescription opioid abuseJeffrey A Gudin
The American Journal of Medicine|September 4, 2007
Opioid agreement or patient-centric action plan?Jeffrey A Gudin
Postgraduate Medicine|December 1, 2015
An overview of prodrug technology and its application for developing abuse-deterrent opioidsJeffrey A Gudin, Srinivas R Nalamachu
Postgraduate Medicine|October 9, 2019
The prescription opioid conundrum: 21st century solutions to a millennia-long problemMichael J Brennan, Jeffrey A Gudin
Pain Medicine (Malden, Mass.)|October 14, 2015
Opioid Related EndocrinopathyJeffrey A Gudin, Adam Laitman, Srinivas Nalamachu
Journal of Pain Research|July 4, 2020
Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the RELIEF StudyJeffrey A Gudin, Derek T Dietze, Peter L Hurwitz
Postgraduate Medicine|August 13, 2013
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol useJeffrey A Gudin, Shanthi Mogali, Jermaine D Jones, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 8, 2013
Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl productsJoseph V Pergolizzi, Christopher G Gharibo, Jeffrey A Gudin, et al.
Pageof 2